239 related articles for article (PubMed ID: 24685443)
1. Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the National Cancer Database: importance of socioeconomic status and treating institution.
Sher DJ; Liptay MJ; Fidler MJ
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):303-12. PubMed ID: 24685443
[TBL] [Abstract][Full Text] [Related]
2. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
Sher DJ; Koshy M; Liptay MJ; Fidler MJ
Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
[TBL] [Abstract][Full Text] [Related]
3. Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis.
Sher DJ; Fidler MJ; Seder CW; Liptay MJ; Koshy M
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):307-16. PubMed ID: 25838187
[TBL] [Abstract][Full Text] [Related]
4. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS
J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer.
Sher DJ; Fidler MJ; Liptay MJ; Koshy M
Lung Cancer; 2015 Jun; 88(3):267-74. PubMed ID: 25862147
[TBL] [Abstract][Full Text] [Related]
6. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
7. Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy.
Broderick SR; Patel AP; Crabtree TD; Bell JM; Morgansztern D; Robinson CG; Kreisel D; Krupnick AS; Patterson GA; Meyers BF; Puri V
Ann Thorac Surg; 2016 Feb; 101(2):451-7; discussion 457-8. PubMed ID: 26410162
[TBL] [Abstract][Full Text] [Related]
8. Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer?
Steger V; Spengler W; Hetzel J; Veit S; Walker T; Mustafi M; Friedel G; Walles T
Eur J Cardiothorac Surg; 2012 Apr; 41(4):880-5; discussion 885. PubMed ID: 22233799
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary Treatment for Stage IIIA Non-Small Cell Lung Cancer: Does Institution Type Matter?
Samson P; Patel A; Crabtree TD; Morgensztern D; Robinson CG; Colditz GA; Waqar S; Kreisel D; Krupnick AS; Patterson GA; Broderick S; Meyers BF; Puri V
Ann Thorac Surg; 2015 Nov; 100(5):1773-9. PubMed ID: 26228601
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer.
Darling GE; Li F; Patsios D; Massey C; Wallis AG; Coate L; Keshavjee S; Pierre A; De Perrot M; Yasufuku K; Cypel M; Waddell T
Eur J Cardiothorac Surg; 2015 Nov; 48(5):684-90; discussion 690. PubMed ID: 25567960
[TBL] [Abstract][Full Text] [Related]
11. Stage IIIA non-small cell lung cancer: morbidity and mortality of three distinct multimodality regimens.
Seder CW; Allen MS; Cassivi SD; Deschamps C; Nichols FC; Olivier KR; Shen KR; Wigle DA
Ann Thorac Surg; 2013 May; 95(5):1708-16. PubMed ID: 23545194
[TBL] [Abstract][Full Text] [Related]
12. Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer.
Takeda S; Maeda H; Okada T; Yamaguchi T; Nakagawa M; Yokota S; Sawabata N; Ohta M
Eur J Cardiothorac Surg; 2006 Jul; 30(1):184-9. PubMed ID: 16730452
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
Tieu BH; Sanborn RE; Thomas CR
Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
[TBL] [Abstract][Full Text] [Related]
14. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.
Weder W; Collaud S; Eberhardt WE; Hillinger S; Welter S; Stahel R; Stamatis G
J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1424-30. PubMed ID: 20416887
[TBL] [Abstract][Full Text] [Related]
15. Sleeve lobectomy after induction chemoradiotherapy.
Gómez-Caro A; Boada M; Reguart N; Viñolas N; Casas F; Molins L
Eur J Cardiothorac Surg; 2012 May; 41(5):1052-8. PubMed ID: 22223693
[TBL] [Abstract][Full Text] [Related]
16. Impact of lung function changes after induction radiochemotherapy on resected T4 non-small cell lung cancer outcome.
Perentes J; Bopp S; Krueger T; Gonzalez M; Jayet PY; Lovis A; Matzinger O; Ruffieux C; Ris HB; Letovanec I; Peters S
Ann Thorac Surg; 2012 Dec; 94(6):1815-22. PubMed ID: 23103000
[TBL] [Abstract][Full Text] [Related]
17. Temporal trends in the management of potentially resectable lung cancer.
Farjah F; Wood DE; Yanez D; Symons RG; Krishnadasan B; Flum DR
Ann Thorac Surg; 2008 Jun; 85(6):1850-5; discussion 1856. PubMed ID: 18498783
[TBL] [Abstract][Full Text] [Related]
18. Trimodality vs Chemoradiation and Salvage Resection in cN2 Stage IIIA Non-Small Cell Lung Cancer.
Ye JC; Ding L; Atay SM; Nieva JJ; McFadden PM; Chang E; Kim AW
Semin Thorac Cardiovasc Surg; 2020; 32(1):153-159. PubMed ID: 31220530
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors for survival in stage IIIA N2 NSCLC patients treated with neoadjuvant CCRT followed by surgery.
Lim HJ; Lee HY; Lee KS; Han J; Kwon OJ; Park K; Ahn YC; Kim BT; Shim YM
Cancer Chemother Pharmacol; 2015 Jan; 75(1):77-85. PubMed ID: 25374409
[TBL] [Abstract][Full Text] [Related]
20. Survival of patients with clinical stage IIIA non-small cell lung cancer after induction therapy: age, mediastinal downstaging, and extent of pulmonary resection as independent predictors.
Paul S; Mirza F; Port JL; Lee PC; Stiles BM; Kansler AL; Altorki NK
J Thorac Cardiovasc Surg; 2011 Jan; 141(1):48-58. PubMed ID: 21092990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
